Haemacure Closes Purchase of Assets by Angiotech Pharmaceuticals

Thursday, April 8, 2010 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

MONTREAL, April 7 /PRNewswire/ - Haemacure Corporation announces the closing of the purchase by Angiotech Pharmaceuticals,

Inc. of substantially all its assets, consisting mainly of its two product candidates and the associated intellectual property and manufacturing plant. The transaction was entered into with authorization from competent courts in Canada
and the United States under the Bankruptcy and Insolvency Act and Chapter 11 of the Bankruptcy Code respectively.

As previously announced, Haemacure filed last January a notice of intention to make a proposal to its creditors in Canada and sought court protection in the United States. Haemacure intends to make such proposal no later than April 19, 2010, as authorized by the court. The recovery of any sums by creditors and shareholders is uncertain.

SOURCE HAEMACURE CORPORATION



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store